SOW
BPMC

State of Wyoming’s Blueprint Medicines BPMC Stock Holding History

State of Wyoming’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,994
Closed -$101K – 1563
2022
Q2 		$101K Buy
1,994
+1,633
+452% +$95.7K 0.06% 495
2022
Q1 		$23K Sell
361
-147
-29% -$10.6K 0.01% 1392
2021
Q4 		$54K Sell
508
-224
-31% -$23.4K 0.03% 1055
2021
Q3 		$75K Sell
732
-283
-28% -$26.4K 0.05% 586
2021
Q2 		$89K Buy
1,015
+558
+122% +$51.1K 0.06% 497
2021
Q1 		$44K Buy
+457
New +$45.6K 0.07% 233

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State of Wyoming's BPMC Position: Q3 2022 in Review

State of Wyoming sold out of Blueprint Medicines (BPMC) in Q3 2022, closing a stake of 1,994 shares — an estimated $101K sold.

State of Wyoming first reported a position in BPMC in Q1 2021 and held it in 6 quarters. The position peaked at $101K in Q2 2022. 240 funds tracked by Wall St. Rank hold BPMC as of Q3 2022.

  • State of Wyoming reported no remaining Blueprint Medicines position as of Q3 2022 after selling out during the quarter.
  • State of Wyoming sold 1,994 Blueprint Medicines shares in Q3 2022, an estimated $101K.
  • State of Wyoming first reported a position in Blueprint Medicines in Q1 2021 and held it in 6 quarters.
  • State of Wyoming's Blueprint Medicines position peaked at $101K in Q2 2022.
  • 240 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.